sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Market History and Outlook of Peptide CDMO Products

Global Market History and Outlook of Peptide CDMO Products

Home / Categories / Healthcare
Global Market History and Outlook of Peptide CDMO Products
Global Market History and Outlook...
Report Code
RO1/135/6742

Publish Date
12/Mar/2022

Pages
106
PRICE
$ 3360/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5800/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 5800/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Table of Content

1 Peptide CDMO Market Scope Analysis Introduction
1.1 Product Definition and Scope Introduction of Peptide CDMO
1.2 Market by Type
1.2.1 Global Peptide CDMO Market Size Growth Rate by Typ
1.2.2 Global Peptide CDMO Market Type Definitio
1.3 Market by Application
1.3.1 Global Peptide CDMO Market Size Growth Rate by Application
1.3.2 Global Peptide CDMO Market Application Definition
1.4 Global Peptide CDMO Market Size Estimates and Forecasts
1.4.1 Global Peptide CDMO Revenue 2017-2028
1.4.2 Global Peptide CDMO Sales 2017-2028
1.4.3 Peptide CDMO Market Size by Region: 2017 Versus 2022 Versus 2028
2 Analysis of Key Market Players
2.1 Global Peptide CDMO Sales by Players
2.1.1 Global Top Peptide CDMO Players by Sales (2017-2022)
2.1.2 Global Top Peptide CDMO Players Market Share by Sales (2017-2022)
2.1.3 Global Top 10 and Top 5 Companies by Peptide CDMO Sales in 2020
2.2 Global Peptide CDMO Revenue by Players
2.2.1 Global Top Peptide CDMO Players by Revenue (2017-2022)
2.2.2 Global Top Peptide CDMO Players Market Share by Revenue (2017-2022)
2.2.3 Global Top 10 and Top 5 Companies by Peptide CDMO Revenue in 2020
2.3 Mergers & Acquisitions, Expansion Plans
2.4 Thermo Fisher Pharma
2.4.1 Thermo Fisher Pharma Corporation Information
2.4.2 Thermo Fisher Pharma Overview
2.4.3 Thermo Fisher Pharma Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.4.4 Thermo Fisher Pharma Peptide CDMO Product Description
2.4.5 Thermo Fisher Pharma Peptide CDMO Related Developments
2.5 PolyPeptide
2.5.1 PolyPeptide Corporation Information
2.5.2 PolyPeptide Overview
2.5.3 PolyPeptide Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.5.4 PolyPeptide Peptide CDMO Product Description
2.5.5 PolyPeptide Peptide CDMO Related Developments
2.6 Bachem
2.6.1 Bachem Corporation Information
2.6.2 Bachem Overview
2.6.3 Bachem Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.6.4 Bachem Peptide CDMO Product Description
2.6.5 Bachem Peptide CDMO Related Developments
2.7 ScinoPharm
2.7.1 ScinoPharm Corporation Information
2.7.2 ScinoPharm Overview
2.7.3 ScinoPharm Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.7.4 ScinoPharm Peptide CDMO Product Description
2.7.5 ScinoPharm Peptide CDMO Related Developments
2.8 CBL
2.8.1 CBL Corporation Information
2.8.2 CBL Overview
2.8.3 CBL Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.8.4 CBL Peptide CDMO Product Description
2.8.5 CBL Peptide CDMO Related Developments
2.9 AmbioPharm
2.9.1 AmbioPharm Corporation Information
2.9.2 AmbioPharm Overview
2.9.3 AmbioPharm Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.9.4 AmbioPharm Peptide CDMO Product Description
2.9.5 AmbioPharm Peptide CDMO Related Developments
2.10 Piramal Pharma
2.10.1 Piramal Pharma Corporation Information
2.10.2 Piramal Pharma Overview
2.10.3 Piramal Pharma Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.10.4 Piramal Pharma Peptide CDMO Product Description
2.10.5 Piramal Pharma Peptide CDMO Related Developments
2.11 CordenPharma
2.11.1 CordenPharma Corporation Information
2.11.2 CordenPharma Overview
2.11.3 CordenPharma Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.11.4 CordenPharma Peptide CDMO Product Description
2.11.5 CordenPharma Peptide CDMO Related Developments
2.12 CPC SCIENTIFIC
2.12.1 CPC SCIENTIFIC Corporation Information
2.12.2 CPC SCIENTIFIC Overview
2.12.3 CPC SCIENTIFIC Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.12.4 CPC SCIENTIFIC Peptide CDMO Product Description
2.12.5 CPC SCIENTIFIC Peptide CDMO Related Developments
2.13 Provepharm
2.13.1 Provepharm Corporation Information
2.13.2 Provepharm Overview
2.13.3 Provepharm Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.13.4 Provepharm Peptide CDMO Product Description
2.13.5 Provepharm Peptide CDMO Related Developments
2.14 Space Peptides
2.14.1 Space Peptides Corporation Information
2.14.2 Space Peptides Overview
2.14.3 Space Peptides Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.14.4 Space Peptides Peptide CDMO Product Description
2.14.5 Space Peptides Peptide CDMO Related Developments
2.15 Biopeptek
2.15.1 Biopeptek Corporation Information
2.15.2 Biopeptek Overview
2.15.3 Biopeptek Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.15.4 Biopeptek Peptide CDMO Product Description
2.15.5 Biopeptek Peptide CDMO Related Developments
2.16 Alpha Biophama
2.16.1 Alpha Biophama Corporation Information
2.16.2 Alpha Biophama Overview
2.16.3 Alpha Biophama Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.16.4 Alpha Biophama Peptide CDMO Product Description
2.16.5 Alpha Biophama Peptide CDMO Related Developments
2.17 Alabiochem
2.17.1 Alabiochem Corporation Information
2.17.2 Alabiochem Overview
2.17.3 Alabiochem Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.17.4 Alabiochem Peptide CDMO Product Description
2.17.5 Alabiochem Peptide CDMO Related Developments
2.18 Aurigene Pharmaceutical Services
2.18.1 Aurigene Pharmaceutical Services Corporation Information
2.18.2 Aurigene Pharmaceutical Services Overview
2.18.3 Aurigene Pharmaceutical Services Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.18.4 Aurigene Pharmaceutical Services Peptide CDMO Product Description
2.18.5 Aurigene Pharmaceutical Services Peptide CDMO Related Developments
2.19 Chengdu Shengnuo Biotechnology Co., Ltd
2.19.1 Chengdu Shengnuo Biotechnology Co., Ltd Corporation Information
2.19.2 Chengdu Shengnuo Biotechnology Co., Ltd Overview
2.19.3 Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.19.4 Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Product Description
2.19.5 Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Related Developments
2.20 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd
2.20.1 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Corporation Information
2.20.2 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Overview
2.20.3 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Sales, Price, Revenue and Gross Margin (2017-2022)
2.20.4 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Product Description
2.20.5 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Related Developments
3 Peptide CDMO Historical and Forecast Market Size by Region
3.1 Global Peptide CDMO Historical and Forecast Sales Market Size by Region
3.2 Global Peptide CDMO Historical and Forecast Revenue Market Size by Region
3.3 {xx} Historical and Forecast Market Size by Country
3.3.1 {xx} Historical and Forecast Sales Market Size by Country (2017-2028)
3.3.2 {xx} Historical and Forecast Revenue Market Size by Country (2017-2028)
4 Market Size by Type
4.1 Global Peptide CDMO Sales by Type
4.1.1 Global Peptide CDMO Historical Sales by Type (2017-2022)
4.1.2 Global Peptide CDMO Forecasted Sales by Type (2023-2028)
4.1.3 Global Peptide CDMO Sales Market Share by Type (2017-2028)
4.2 Global Peptide CDMO Revenue by Type
4.2.1 Global Peptide CDMO Historical Revenue by Type (2017-2022)
4.2.2 Global Peptide CDMO Forecasted Revenue by Type (2023-2028)
4.2.3 Global Peptide CDMO Revenue Market Share by Type (2017-2028)
4.3 Global Peptide CDMO Price by Type
4.3.1 Global Peptide CDMO Price by Type (2017-2022)
4.3.2 Global Peptide CDMO Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Peptide CDMO Sales by Application
5.1.1 Global Peptide CDMO Historical Sales by Application (2017-2022)
5.1.2 Global Peptide CDMO Forecasted Sales by Application (2023-2028)
5.1.3 Global Peptide CDMO Sales Market Share by Application (2017-2028)
5.2 Global Peptide CDMO Revenue by Application
5.2.1 Global Peptide CDMO Historical Revenue by Application (2017-2022)
5.2.2 Global Peptide CDMO Forecasted Revenue by Application (2023-2028)
5.2.3 Global Peptide CDMO Revenue Market Share by Application (2017-2028)
5.3 Global Peptide CDMO Price by Application
5.3.1 Global Peptide CDMO Price by Application (2017-2022)
5.3.2 Global Peptide CDMO Price Forecast by Application (2023-2028)
6 Peptide CDMO Manufacturing Cost Analysis
6.1 Peptide CDMO Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Key Suppliers of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.3 Manufacturing Process Analysis of Peptide CDMO
6.4 Peptide CDMO Industrial Chain Analysis
7 Marketing Channel, Distributors and Customers
7.1 Marketing Channel
7.2 Peptide CDMO Distributors List
7.3 Peptide CDMO Customers
8 Peptide CDMO Market Dynamics
8.1 Peptide CDMO Industry Trends
8.2 Peptide CDMO Growth Drivers
8.3 Peptide CDMO Market Challenges
8.4 Peptide CDMO Market Restraints
9 Summary of research findings
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.2.3 Legal Disclaimer

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com